U.S. Pharmacy Benefit Management Market to reach USD 947.90 billion by 2032 at a CAGR of 9.13%
Pharmacy Benefit Managers (PBMs) are a key player in the drug supply chain, acting as gatekeepers for both which drugs patients can get and how much they pay. There is a lack of transparency in how PBMs make these decisions, leaving consumers and policymakers in the dark about how PBMs might be impacting medication affordability.